Advanced Enzyme Technologies Limited
NSE: ADVENZYMES.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Beni Prasad Rauka
- Employees
- 323
- Headquarters
- Thane, India
- IPO year
- 2016
- Market cap
- ₹40.0B
- Website
- https://www.advancedenzymes.com
Loading ADVENZYMES…
Loading profile data…Frequently asked questions about ADVENZYMES
What does Advanced Enzyme Technologies Limited (ADVENZYMES.NS) do?
Advanced Enzyme Technologies Limited researches and develops, manufactures, and markets enzymes and probiotics in India, the United States, Asia, Europe, and internationally. The company offers enzymes for human healthcare and animal nutrition, fruit and vegetable processing, baking, brewing, and malting, and grain processing, protein modificati...
Where does ADVENZYMES.NS trade?
Advanced Enzyme Technologies Limited (ADVENZYMES.NS) trades on the National Stock Exchange of India.
What sector is ADVENZYMES.NS in?
Advanced Enzyme Technologies Limited (ADVENZYMES.NS) operates in the Basic Materials sector, specifically in the Chemicals - Specialty industry.
Who is the CEO of Advanced Enzyme Technologies Limited?
Beni Prasad Rauka is the chief executive officer of Advanced Enzyme Technologies Limited (ADVENZYMES.NS).
Where is Advanced Enzyme Technologies Limited headquartered?
Advanced Enzyme Technologies Limited is headquartered in India.
Does ADVENZYMES.NS pay a dividend?
Yes — Advanced Enzyme Technologies Limited (ADVENZYMES.NS) paid a trailing twelve-month dividend of INR 5.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did ADVENZYMES.NS go public?
Advanced Enzyme Technologies Limited (ADVENZYMES.NS) completed its initial public offering in 2016.